SNT
Click for more information
3.03% 3.2¢ syntara limited

Ann: PXS Announces Encouraging Results from Phase 1c Scar Study, page-2

  1. 84pp
    286 Posts.
    lightbulb Created with Sketch. 51
    clock Created with Sketch.
    23/05/23
    17:00
    Post #: 67922053
    The point of this trial was to see any evident scar shrinkage or removal of scar & skin regeneration...!
    neither has been achieved not sure what are they pleased and excited about?.

    Disappointing results, drug/formulation not doing what it's supposed to do.
    Last edited by 84pp: 23/05/23
    Likes Created with Sketch. 2  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

SBW Shekel Brainweigh provides key business update ahead of final 2024 quarter
right-arrow Created with Sketch.
watchlist Created with Sketch. Add SNT (ASX) to my watchlist
(20min delay)
Last
3.2¢ 		Change
-0.001(3.03%) 		Mkt cap ! $41.29M
Open High Low Value Volume
3.3¢ 3.3¢ 3.2¢ $92.34K 2.853M

Buyers (Bids)

No. Vol. Price($)
1 384 3.2¢
 

Sellers (Offers)

Price($) Vol. No.
3.3¢ 443289 1
View Market Depth
Last trade - 16.10pm 23/08/2024 (20 minute delay) ?
SNT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.